Focus. True gold and silver support the biopharmaceutical industry Lanzhou High-tech Zone issued 20 biopharmaceutical industry development policies.

Guide: Applicable to register and pay taxes in Lanzhou High-tech Zone, with independent legal personality, engaged in biopharmaceutical research and development, production and service enterprises and institutions, probationary period of two yearsOn June 30,, Lanzhou High-tech District held the 26th China Lanzhou Investment and Trade Fair special signing ceremony and biopharmaceutical policy launchThe policy on "Several Measures to Speed up the Development of the Biopharmaceutical Industry" was issued, a total of 20, which applies to enterprises and institutions registered and taxed in lanzhou High-tech Zone, have independent legal personality, and engage in research and development, production and service of biomedicine, with a probationary period of two yearsreal gold and silver to support the biopharmaceutical industry - Lanzhou High-tech Zone issued 20 biopharmaceutical industry development policies
in order to support the biopharmaceutical industry landing, Lanzhou High-tech Zone for new investment in biomedical research and development, production and medical big data, Internet medical and other projects, fixed assets (excluding land) actual investment of 50 million yuan (inclusive), after completion and acceptance according to 10% of the actual amount of investment to give a one-time reward, a single project reward of up to 10 million yuanNewly introduced innovative drugs, the first imitation drug project after the identification can be identified to build plant and necessary supporting facilitiesin order to support the development of the headquarters of biopharmaceutical enterprises, Lanzhou High-tech Zone in the world 500, China 500, private 100 or domestic and foreign listed biopharmaceutical enterprises set up regional headquarters in Lanzhou High-tech Zone and continue to operate for more than 3 years, and in Lanzhou High-tech Zone statistical accounting output value of not less than 10 In the first three years, the company pays income tax in the high-tech zone to obtain 50% of the reward, which in the region set up with independent legal personality research and development center, in accordance with the research and development center in the last year approved 20% of the additional support, up to 10 million yuanto support biopharmaceutical research and development innovation, Lanzhou High-tech Zone for clinical trials in China and transformation of new drugs in the region, according to its research and development progress in stages to fundEnterprises that have obtained clinical approval of new National Class I drugs (including Chinese medicine and natural medicines, chemicals and biological products) shall be supported at 40% of the actual investment in research and development costs, up to a maximum of 5 million yuanThe completion of Phase I, II, III clinical trials, respectively, up to 8 million, 12 million, 20 million yuan to give financial support, a single enterprise annual funding of up to 20 million yuanFor the national 2 chemicals, 2-5 biological products, 2-6 chinese medicine and natural medicines that have obtained clinical approval, the funding shall be provided at 40% of the actual investment in research and development costs, up to a maximum of 2 million yuanThe completion of Phase I, II, III clinical trials, respectively, up to 2 million, 5 million, 10 million yuan to give financial support, a single enterprise annual funding of up to 10 million yuanFor generic drugs (Chinese medicines and natural drugs, chemicals, biological products) that have obtained the drug approval number, they will be supported at 20% of the actual investment in research and development, up to a maximum of 3 million yuan;in order to support the transformation of scientific research achievements in Chinese medicine, Lanzhou High-tech District for new grants to the national or provincial scientific research projects, according to the higher-level funding of 30% to give a one-time awardIf a new national invention patent is granted to the inventor of the new national invention patent, a one-time reward of 50,000 yuan shall be given to the inventorto support the development of medical devices, Lanzhou High-tech Zone for the new access to three types of innovative medical devices or Class A, B large-scale medical equipment registered certificate of enterprises, a single product to give 500,000 yuan a one-time reward; In the current year, each enterprise cumulative reward of up to 1 million yuan in order to support biopharmaceutical enterprises to expand production, Lanzhou High-tech Zone supports the production of licensed products for biopharmaceutical enterprises with approved numbers (sleep or idle) that do not have production conditions It was determined that the product's annual sales of 5% of the reward, up to 100,000 yuan in support of biopharmaceutical commissioned production, Lanzhou High-tech Zone to support the acquisition of pharmaceutical or medical device listing license holders (registered) commissioned enterprises in the region to produce the listed licensed products, from the beginning of production of the products in accordance with the actual commissioned production contract of each variety within three years of 5% of the actual delivery of the production contract (based on invoices) to the entrusted production enterprises Single variety three-year cumulative reward each enterprise up to 1 million yuan, the same enterprise annual reward up to 2 million yuan, three-year cumulative reward up to 3 million yuan on the first purchase of the biopharmaceutical government, Lanzhou High-tech Zone for the first time on the market of innovative products to implement the first purchase and priority procurement of the government For innovative products such as innovative drugs, first imitation drugs, high-value medical supplies, testing and testing reagents and medical equipment in the procurement area of local medical institutions, a reward of 5% of the purchase amount shall be given, and the total amount of the award for a single medical institution in the same year can be up to 3 million yuan on the construction of the public platform for biomedicine, Lanzhou High-tech District has given a one-time award of 5 million yuan to the newly approved national medical center, national regional medical center, national clinical medical research center, key laboratory of national ministries and other innovative platforms For new projects on public research and development platforms above the provincial level of the biopharmaceutical industry, a one-time subsidy shall be granted to the purchasing unit according to 20% of the purchase amount of new equipment (including supporting software), and a subsidy for a single project can be up to 3 million yuan In order to support biomedical qualification certification, Lanzhou High-tech District has provided financial support to new biopharmaceutical enterprises or institutions that have passed the new National Drug Non-Clinical Research Quality Management Practice (GLP), Drug (including Medical Devices) Clinical Trial Quality Management Practice (GCP), and China National Accreditation Committee for Conformity Assessment (CNAS) Among them, the first to obtain GLP certification project to achieve three major items, five major items, respectively, to give 1 million yuan, 2 million yuan reward; For the new FDA (U.S Food and Drug Administration), EMA (European Drug Administration), PMDA (Japan Drug and Medical Devices Agency), CE certification and other international authoritative certification of pharmaceutical and medical device enterprises, each product annual export of more than 1 million U.S dollars, 3% of the reward, a maximum reward of 1 million yuan for a single product Each enterprise in the year of the cumulative reward of up to 3 million yuan in order to support the technological transformation of biopharmaceutical enterprises, Lanzhou High-tech Zone for biopharmaceutical enterprises using industrial Internet, big data, artificial intelligence and other technologies to carry out technical transformation of existing production facilities, process equipment of outstanding projects, after evaluation and classification of graded, up to 20% of the project investment amount to be funded, a single enterprise annual funding of up to 5 million yuan in order to support the introduction of biomedical talents, Lanzhou High-tech District for the identified bio-pharmaceutical category of high-level personnel salary income personal income tax in the first three years in accordance with the annual tax amount of 100% of the incentive, the next two years in accordance with 50% of the reward For bio-medicine and other industry talentto open up a green channel for job title evaluation, eligible can be directly awarded the corresponding title Strengthen the protection of talents living in a happy home, to the qualified bio-medicine high-level talent to give up to 2 million yuan of housing subsidies, according to the contribution of talent to the local, to give up to 1 million yuan contribution incentives Improve the "one-stop" service system for high-level talents, and provide qualified biopharmaceutical industry talents with preferential treatment such as talent settlement, medical security and children's education in addition, in the biomedical financial support, actively encourage all kinds of financial institutions in Lanto to increase investment in lanzhou high-tech district biopharmaceutical enterprises or projects Support high-quality biopharmaceutical enterprises to make full use of domestic and foreign multi-level capital market listing financing, broaden direct financing channels For biopharmaceutical enterprises that achieve IPOs in the capital market, a maximum of 5 million yuan each is awarded according to regulations The establishment of a biopharmaceutical industry development investment fund, play a role in guiding financial funds, the introduction of social capital, market-oriented participation or the establishment of a large health industry fund covering project landing, equity investment, new drug introduction and overseas medical services and other fields, to build a biomedical and medical health industry fund group, investment and promote related innovation projects settled in Lanzhou High-tech District Increase support for start-up biopharmaceutical enterprises, focus on supporting new drugs, innovative medical device projects and biopharmaceutical industrial park construction, the region to obtain equity investment in seed-stage projects or start-up enterprises, in accordance with the actual investment of 10% of the investment institutions to give subsidies, a single subsidy of up to 500,000 yuan, a single investment institution spent a total of 2 million yuan per year At the , Sun Yu, a member of the Party Committee of Lanzhou High-tech District and director of the Management Committee, said that biomedicine will be the main industry, the implementation of the action plan for the cultivation of innovative biomedicine enterprises, the collection of various elements of resources, the first cultivation, the first foster, the formation of biopharmaceutical industry clusters focusing on biopharmaceutical, modern Chinese medicine, biomedical engineering and animal medicine, to create a number of more competitive and influential biopharmaceutical brands , the results of the Framework Agreement on Strategic Cooperation between Lanzhou High-tech Zone and Gansu Provincial Drug Supervision Bureau were signed, and the two companies will jointly build a policy and technical service window, a biopharmaceutical research and development platform, an education and training base, a platform for the issuance and inspection of biological products, and a research and development platform for the Gansu Pharmaceutical Industry Research Institute .